Molecular Imaging and Radionuclide Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 0.9 | Q4 | 13.4% | 0.274 | Q3 | 40.2% |
| 2024 | 1.1 | Q4 | 22.0% | 0.275 | Q3 | 42.8% |
| 2023 | 0.9 | Q4 | 19.0% | 0.272 | Q3 | 45.7% |
| 2022 | 0.9 | 15.1% | 0.228 | Q3 | 42.0% | |
| 2021 | — | 32.6% | 0.216 | Q4 | 41.4% | |
| 2020 | — | — | 0.292 | Q3 | 49.4% | |
| 2019 | — | — | 0.349 | Q3 | 57.0% | |
| 2018 | — | — | 0.335 | Q3 | 53.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2146-1414
ISSN
2147-1959
country
TRcoverage
2017-2026